Sacubitril-valsartan in heart failure and multimorbidity patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sacubitril-valsartan in heart failure and multimorbidity patients

Published:2018-07-24 Issue:5 Volume:5 Page:956-959
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Rodil Fraile Raquel¹^ORCID,Malafarina Vincenzo²³,Tiberio López Gregorio¹

Affiliation:

1. Internal Medicine Department, Chronic-Multimorbidity Unit; Complejo Hospitalario de Navarra; Irunlarrea, 34 31008 Pamplona Spain

2. Geriatric Department, Chronic-Multimorbidity Unit; Complejo Hospitalario de Navarra; Irunlarrea, 34 31008 Pamplona Spain

3. Department of Nutrition, Food Science and Physiology, Faculty of Pharmacy and Nutrition; University of Navarra; 31008 Pamplona Spain

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ehf2.12338/fullpdf

Reference9 articles.

1. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry;Chioncel;Eur J Heart Fail,2017

2. Multimorbidity in heart failure: a community perspective;Chamberlain;Am J Med,2015

3. Multimorbidity in heart failure: impact on outcomes;Manemann;J Am Geriatr Soc,2016

4. Angiotensin-neprilysin inhibition versus enalapril in heart failure;McMurray;N Engl J Med,2014

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of sacubitril/valsartan on the functional capacity of real-world patients in Italy: the REAL.IT study on heart failure with reduced ejection fraction;Frontiers in Cardiovascular Medicine;2024-05-10

2. Efficacy and safety of low‐dose sacubitril/valsartan in heart failure patients: A systematic review and meta‐analysis;Clinical Cardiology;2023-01-17

3. Practical management of frailty in older patients with heart failure;ESC Heart Failure;2022-08-30

4. Role of new drug therapies and innovative procedures in older patients with heart failure: from trials to clinical practice;Minerva Medica;2022-08

5. Predictors of sacubitril/valsartan high dose tolerability in a real world population with HFrEF;ESC Heart Failure;2022-06-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3